Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Librera OncoLink / Revisiones de Libros, Música y Videos / / Referencia
John Han-Chih Chang, MD
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 1 de noviembre del 2001
![]() |
Author: Kenneth Offit, M.D., M.P.H.
Publisher: John Wiley & Sons, Inc. Publication, 1998 Format: Hardcover, 419 pages ISBN: 0-471-14655-2 OncoLink Rating: |
Dr. Offit graduated from Princeton University, and received his M.D. and M.P.H. from Harvard. He is currently Chief of the Clinical Genetics Service in the Department of Human Genetics at Memorial Sloan-Kettering Cancer Center. He is actively involved in the research of cancer genetics, and has seen an increase in the use of cancer genetics testing. He, thus, wrote this book to be a guide to all health care professionals, explaining the methodologies of cancer genetics testing, and alerting them to the ethical, psychological and legal issues.
The book is divided into ten chapters, with the first chapter providing an overview of clinical cancer genetics and risk counseling. It explains that the focus of genetics testing is on presymptomatic risk assessment. However, it is fast being used for reproductive risk counseling along with diagnostic and prognostic cancer genetics. The first chapter also details how genetic counseling should be done: what a physical exam should include, how to take a medical history and construct a pedigree, and what a counselor should achieve in a counseling session.
The second chapter describes hereditary risks and acquired risks for cancer. In discussing hereditary risks, the book covers different patterns of inheritance, such as Mendelian inheritance, dominant inheritance, recessive inheritance, X-linked inheritance, and non-Mendelian inheritance. Examples of different cancers that follow these patterns are provided. In discussing acquired risks, factors such as environmental and dietary problems are discussed. Again, examples are provided.
Chapter three is a brief but provides a helpful genetics lesson covering the intricacies of DNA structure, genes, mutations (missense, nonsense and frameshift), tumor suppressor genes, cell cycle, oncogenes, and more. The next chapter lists and explains the common hereditary cancers: breast, ovarian, colon and prostate. It discusses clinical and epidemiologic features, risk factors, pathology and frequency. Chapter five is entitled "Other Cancer Predisposition Syndromes," and is similar to chapter four, but delves into the less common entities that predispose to malignancies listed above.
Chapter six is titled "Quantitative Methods in Cancer Risk Assessment," and it describes the derivation of cancer risk figures. The techniques used are based on "...population-derived (epidemiologic) risks, pedigree-derived (genetic epidemiologic) risks and risks deduced by direct genetic testing." This chapter explains equations and provides tables with risk ratios for different cancers.
Chapter seven briefly describes cancer genetics laboratory tests. A few examples are cytogenetic analysis, Southern and Northern blots, and Polymerase Chain Reaction (PCR). The book does not describe how they are performed, rather, it discusses the theory behind each test, and what purpose they serve.
Chapter eight discusses the fact that genetic testing can affect the management of cancer patients. Prognosis for cancer patients can be affected by tumor-associated and inherited genetic markers. This genetic information can be used along with pathologic and clinical data to shape treatment decisions.
Chapter nine is the shortest chapter, and is entitled "Reproductive Counseling for Cancer Patients and Families." The fact that it is so terse illustrates the main point of the chapter, which is that much more research is needed.
Chapter ten, the final chapter, addresses psychological, ethical, and legal issues in cancer risk counseling. The psychological aspect of genetic counseling was defined by Seymour Kessler, who explained that counseling can be content-oriented or person-oriented. Counselors advocate person-oriented counseling, emphasizing the importance of empathy, respect, positive regard and genuineness. The ethical aspect of genetic counseling was defined by Beauchamp and Childress, with the most emphasized aspect of their theory being the importance of the autonomy of the patient. The book then addresses legal issues, citing different state legislations.
This book is a valuable reference to any health care professional involved in cancer risk counseling. It covers a broad spectrum of topics, and although it can only provide an overview of each subject, it cites references should the reader be interested in learning more.
Common misconceptions and myths about pain medication and pain control. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

